nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—PTGS2—skin cancer	0.639	1	CbGaD
Icosapent—PPARG—dermis—skin cancer	0.0114	0.0644	CbGeAlD
Icosapent—TRPV1—nerve—skin cancer	0.01	0.0565	CbGeAlD
Icosapent—PPARG—leg—skin cancer	0.00756	0.0425	CbGeAlD
Icosapent—PPARG—forelimb—skin cancer	0.0075	0.0422	CbGeAlD
Icosapent—PPARG—hindlimb—skin cancer	0.00675	0.038	CbGeAlD
Icosapent—PPARG—appendage—skin cancer	0.00579	0.0326	CbGeAlD
Icosapent—FADS1—nipple—skin cancer	0.0057	0.0321	CbGeAlD
Icosapent—FFAR1—Peptide hormone metabolism—EXOC2—skin cancer	0.00523	0.0577	CbGpPWpGaD
Icosapent—ACSL4—nipple—skin cancer	0.00518	0.0291	CbGeAlD
Icosapent—ACSL3—female reproductive system—skin cancer	0.00516	0.029	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Vismodegib—skin cancer	0.0048	0.0533	CcSEcCtD
Icosapent—FABP7—connective tissue—skin cancer	0.00446	0.0251	CbGeAlD
Icosapent—ACSL3—head—skin cancer	0.00431	0.0243	CbGeAlD
Icosapent—SLC8A1—female reproductive system—skin cancer	0.00427	0.0241	CbGeAlD
Icosapent—PTGS2—leg—skin cancer	0.00386	0.0217	CbGeAlD
Icosapent—TRPV1—epithelium—skin cancer	0.00384	0.0216	CbGeAlD
Icosapent—FADS1—PPARA activates gene expression—PLIN2—skin cancer	0.00376	0.0415	CbGpPWpGaD
Icosapent—FADS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.00368	0.0406	CbGpPWpGaD
Icosapent—ACSL4—connective tissue—skin cancer	0.00367	0.0207	CbGeAlD
Icosapent—SLC8A1—head—skin cancer	0.00357	0.0201	CbGeAlD
Icosapent—PPARG—endothelium—skin cancer	0.00349	0.0197	CbGeAlD
Icosapent—PTGS2—hindlimb—skin cancer	0.00345	0.0194	CbGeAlD
Icosapent—SLC8A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC12A2—skin cancer	0.00334	0.0369	CbGpPWpGaD
Icosapent—FADS1—mammalian vulva—skin cancer	0.00333	0.0187	CbGeAlD
Icosapent—PPARG—blood vessel—skin cancer	0.00322	0.0181	CbGeAlD
Icosapent—Malnutrition—Vismodegib—skin cancer	0.00321	0.0356	CcSEcCtD
Icosapent—Dysgeusia—Vismodegib—skin cancer	0.00315	0.0349	CcSEcCtD
Icosapent—FABP7—female reproductive system—skin cancer	0.00314	0.0177	CbGeAlD
Icosapent—ACSL3—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.00303	0.0334	CbGpPWpGaD
Icosapent—ACSL4—mammalian vulva—skin cancer	0.00302	0.017	CbGeAlD
Icosapent—PTGS2—appendage—skin cancer	0.00296	0.0166	CbGeAlD
Icosapent—PPARD—mammalian vulva—skin cancer	0.0029	0.0163	CbGeAlD
Icosapent—TRPV1—female reproductive system—skin cancer	0.00285	0.016	CbGeAlD
Icosapent—PPARD—Adipogenesis—ASIP—skin cancer	0.00276	0.0304	CbGpPWpGaD
Icosapent—Arthralgia—Vismodegib—skin cancer	0.00273	0.0303	CcSEcCtD
Icosapent—FABP7—head—skin cancer	0.00263	0.0148	CbGeAlD
Icosapent—ACSL4—female reproductive system—skin cancer	0.00259	0.0146	CbGeAlD
Icosapent—PPARD—lymphoid tissue—skin cancer	0.00258	0.0145	CbGeAlD
Icosapent—FADS1—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.00253	0.028	CbGpPWpGaD
Icosapent—PPARD—female reproductive system—skin cancer	0.00249	0.014	CbGeAlD
Icosapent—PTGS2—skin epidermis—skin cancer	0.00246	0.0138	CbGeAlD
Icosapent—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00239	0.0265	CcSEcCtD
Icosapent—TRPV1—head—skin cancer	0.00238	0.0134	CbGeAlD
Icosapent—PPARG—nipple—skin cancer	0.00233	0.0131	CbGeAlD
Icosapent—Dyspepsia—Vismodegib—skin cancer	0.00231	0.0256	CcSEcCtD
Icosapent—PPARG—neck—skin cancer	0.00231	0.013	CbGeAlD
Icosapent—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.00229	0.0253	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Vismodegib—skin cancer	0.00226	0.0251	CcSEcCtD
Icosapent—Constipation—Vismodegib—skin cancer	0.00224	0.0249	CcSEcCtD
Icosapent—ACSL4—head—skin cancer	0.00216	0.0122	CbGeAlD
Icosapent—Dihomo-gamma-linolenic acid—PTGS2—skin cancer	0.00215	1	CrCbGaD
Icosapent—PPARD—head—skin cancer	0.00208	0.0117	CbGeAlD
Icosapent—Malnutrition—Vemurafenib—skin cancer	0.00198	0.022	CcSEcCtD
Icosapent—Dysgeusia—Vemurafenib—skin cancer	0.00194	0.0215	CcSEcCtD
Icosapent—PTGS1—endothelium—skin cancer	0.00187	0.0105	CbGeAlD
Icosapent—Pruritus—Vismodegib—skin cancer	0.00185	0.0206	CcSEcCtD
Icosapent—TRPV1—Trk receptor signaling mediated by the MAPK pathway—BRAF—skin cancer	0.00183	0.0202	CbGpPWpGaD
Icosapent—PTGS2—endothelium—skin cancer	0.00179	0.01	CbGeAlD
Icosapent—PTGS1—blood vessel—skin cancer	0.00172	0.00969	CbGeAlD
Icosapent—Oropharyngeal pain—Docetaxel—skin cancer	0.0017	0.0188	CcSEcCtD
Icosapent—Malnutrition—Imiquimod—skin cancer	0.00169	0.0188	CcSEcCtD
Icosapent—Arthralgia—Vemurafenib—skin cancer	0.00169	0.0187	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.00168	0.0186	CcSEcCtD
Icosapent—PPARD—Adipogenesis—PLIN2—skin cancer	0.00167	0.0184	CbGpPWpGaD
Icosapent—FADS1—lymph node—skin cancer	0.00167	0.00939	CbGeAlD
Icosapent—Vomiting—Vismodegib—skin cancer	0.00167	0.0185	CcSEcCtD
Icosapent—Rash—Vismodegib—skin cancer	0.00165	0.0183	CcSEcCtD
Icosapent—PPARG—connective tissue—skin cancer	0.00165	0.0093	CbGeAlD
Icosapent—Dermatitis—Vismodegib—skin cancer	0.00165	0.0183	CcSEcCtD
Icosapent—PTGS2—blood vessel—skin cancer	0.00165	0.00927	CbGeAlD
Icosapent—Anaphylactic shock—Vemurafenib—skin cancer	0.00162	0.018	CcSEcCtD
Icosapent—PPARG—epithelium—skin cancer	0.00157	0.00883	CbGeAlD
Icosapent—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00152	0.0168	CcSEcCtD
Icosapent—ACSL4—lymph node—skin cancer	0.00152	0.00853	CbGeAlD
Icosapent—PPARG—Adipogenesis—ASIP—skin cancer	0.00151	0.0166	CbGpPWpGaD
Icosapent—SLC8A1—SLC-mediated transmembrane transport—SLC12A2—skin cancer	0.00149	0.0165	CbGpPWpGaD
Icosapent—PPARG—skin of body—skin cancer	0.00149	0.00839	CbGeAlD
Icosapent—Alanine aminotransferase increased—Temozolomide—skin cancer	0.00149	0.0165	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00148	0.0164	CcSEcCtD
Icosapent—PPARD—lymph node—skin cancer	0.00145	0.00818	CbGeAlD
Icosapent—Arthralgia—Imiquimod—skin cancer	0.00144	0.016	CcSEcCtD
Icosapent—Gastrointestinal disorder—Vemurafenib—skin cancer	0.0014	0.0155	CcSEcCtD
Icosapent—Constipation—Vemurafenib—skin cancer	0.00138	0.0154	CcSEcCtD
Icosapent—PPARG—mammalian vulva—skin cancer	0.00136	0.00766	CbGeAlD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00132	0.0146	CbGpPWpGaD
Icosapent—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.00129	0.0142	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00126	0.014	CcSEcCtD
Icosapent—PTGS1—nipple—skin cancer	0.00125	0.00701	CbGeAlD
Icosapent—Dyspepsia—Imiquimod—skin cancer	0.00122	0.0135	CcSEcCtD
Icosapent—PPARG—lymphoid tissue—skin cancer	0.00121	0.0068	CbGeAlD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.0012	0.0133	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—PTCH2—skin cancer	0.00119	0.0132	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Imiquimod—skin cancer	0.00119	0.0132	CcSEcCtD
Icosapent—PPARG—female reproductive system—skin cancer	0.00117	0.00656	CbGeAlD
Icosapent—TRPV1—Trk receptor signaling mediated by the MAPK pathway—NRAS—skin cancer	0.00115	0.0127	CbGpPWpGaD
Icosapent—Pruritus—Vemurafenib—skin cancer	0.00115	0.0127	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00113	0.0125	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—skin cancer	0.0011	0.0121	CbGpPWpGaD
Icosapent—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.00104	0.0115	CbGpPWpGaD
Icosapent—PPARG—PPARA activates gene expression—PLIN2—skin cancer	0.00104	0.0115	CbGpPWpGaD
Icosapent—Vomiting—Vemurafenib—skin cancer	0.00103	0.0114	CcSEcCtD
Icosapent—Rash—Vemurafenib—skin cancer	0.00102	0.0113	CcSEcCtD
Icosapent—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PLIN2—skin cancer	0.00102	0.0113	CbGpPWpGaD
Icosapent—Dermatitis—Vemurafenib—skin cancer	0.00102	0.0113	CcSEcCtD
Icosapent—Malnutrition—Temozolomide—skin cancer	0.00101	0.0112	CcSEcCtD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.00101	0.0111	CbGpPWpGaD
Icosapent—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.00101	0.0112	CcSEcCtD
Icosapent—Dysgeusia—Temozolomide—skin cancer	0.000993	0.011	CcSEcCtD
Icosapent—TRPV1—Trk receptor signaling mediated by the MAPK pathway—KRAS—skin cancer	0.000991	0.0109	CbGpPWpGaD
Icosapent—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000988	0.011	CcSEcCtD
Icosapent—FFAR1—Metabolism of proteins—EXOC2—skin cancer	0.000987	0.0109	CbGpPWpGaD
Icosapent—Anaphylactic shock—Bleomycin—skin cancer	0.000981	0.0109	CcSEcCtD
Icosapent—Pruritus—Imiquimod—skin cancer	0.000977	0.0108	CcSEcCtD
Icosapent—PPARG—head—skin cancer	0.000973	0.00548	CbGeAlD
Icosapent—PPARG—Regulation of retinoblastoma protein—MITF—skin cancer	0.000959	0.0106	CbGpPWpGaD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—skin cancer	0.000946	0.0104	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000913	0.0101	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—PLIN2—skin cancer	0.000913	0.0101	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000894	0.00991	CcSEcCtD
Icosapent—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—skin cancer	0.000886	0.00977	CbGpPWpGaD
Icosapent—PTGS1—connective tissue—skin cancer	0.000883	0.00497	CbGeAlD
Icosapent—Vomiting—Imiquimod—skin cancer	0.000878	0.00974	CcSEcCtD
Icosapent—PPARD—Ectoderm Differentiation—SHH—skin cancer	0.000873	0.00963	CbGpPWpGaD
Icosapent—Rash—Imiquimod—skin cancer	0.000871	0.00966	CcSEcCtD
Icosapent—Dermatitis—Imiquimod—skin cancer	0.00087	0.00965	CcSEcCtD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.000869	0.00959	CbGpPWpGaD
Icosapent—Arthralgia—Temozolomide—skin cancer	0.000863	0.00957	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—MC1R—skin cancer	0.000862	0.00951	CbGpPWpGaD
Icosapent—PTGS2—connective tissue—skin cancer	0.000844	0.00475	CbGeAlD
Icosapent—TRPV1—Trk receptor signaling mediated by the MAPK pathway—HRAS—skin cancer	0.000842	0.00929	CbGpPWpGaD
Icosapent—PTGS1—epithelium—skin cancer	0.000839	0.00472	CbGeAlD
Icosapent—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000834	0.00925	CcSEcCtD
Icosapent—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.00083	0.00915	CbGpPWpGaD
Icosapent—Anaphylactic shock—Temozolomide—skin cancer	0.000828	0.00918	CcSEcCtD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—skin cancer	0.000804	0.00887	CbGpPWpGaD
Icosapent—PTGS2—epithelium—skin cancer	0.000801	0.00451	CbGeAlD
Icosapent—PTGS1—skin of body—skin cancer	0.000798	0.00449	CbGeAlD
Icosapent—Anaphylactic shock—Fluorouracil—skin cancer	0.000763	0.00846	CcSEcCtD
Icosapent—PTGS2—skin of body—skin cancer	0.000762	0.00429	CbGeAlD
Icosapent—SLC8A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000759	0.00838	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000754	0.00836	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000745	0.00822	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—RHOU—skin cancer	0.00074	0.00817	CbGpPWpGaD
Icosapent—TRPV1—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000733	0.00809	CbGpPWpGaD
Icosapent—Dyspepsia—Temozolomide—skin cancer	0.000729	0.00808	CcSEcCtD
Icosapent—PTGS1—mammalian vulva—skin cancer	0.000727	0.00409	CbGeAlD
Icosapent—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—skin cancer	0.000726	0.008	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Temozolomide—skin cancer	0.000715	0.00792	CcSEcCtD
Icosapent—Constipation—Temozolomide—skin cancer	0.000708	0.00785	CcSEcCtD
Icosapent—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—PLIN2—skin cancer	0.000704	0.00776	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000695	0.00771	CcSEcCtD
Icosapent—Pruritus—Bleomycin—skin cancer	0.000694	0.0077	CcSEcCtD
Icosapent—PPARG—lymph node—skin cancer	0.000682	0.00384	CbGeAlD
Icosapent—Malnutrition—Docetaxel—skin cancer	0.000674	0.00748	CcSEcCtD
Icosapent—Dyspepsia—Fluorouracil—skin cancer	0.000671	0.00744	CcSEcCtD
Icosapent—Dysgeusia—Docetaxel—skin cancer	0.00066	0.00732	CcSEcCtD
Icosapent—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000658	0.0073	CcSEcCtD
Icosapent—Vomiting—Bleomycin—skin cancer	0.000624	0.00692	CcSEcCtD
Icosapent—PTGS1—female reproductive system—skin cancer	0.000623	0.00351	CbGeAlD
Icosapent—Rash—Bleomycin—skin cancer	0.000619	0.00686	CcSEcCtD
Icosapent—Dermatitis—Bleomycin—skin cancer	0.000618	0.00685	CcSEcCtD
Icosapent—PTGS2—lymphoid tissue—skin cancer	0.000617	0.00347	CbGeAlD
Icosapent—FFAR1—GPCR ligand binding—SHH—skin cancer	0.000614	0.00678	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—PTCH2—skin cancer	0.000612	0.00675	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—NKX2-1—skin cancer	0.000611	0.00674	CbGpPWpGaD
Icosapent—PTGS2—female reproductive system—skin cancer	0.000595	0.00335	CbGeAlD
Icosapent—Pruritus—Temozolomide—skin cancer	0.000586	0.00649	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—SMO—skin cancer	0.000582	0.00643	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—PTCH1—skin cancer	0.000582	0.00643	CbGpPWpGaD
Icosapent—Vomiting—Dactinomycin—skin cancer	0.000582	0.00645	CcSEcCtD
Icosapent—Rash—Dactinomycin—skin cancer	0.000577	0.0064	CcSEcCtD
Icosapent—Arthralgia—Docetaxel—skin cancer	0.000574	0.00637	CcSEcCtD
Icosapent—PTGS1—Overview of nanoparticle effects—PTGS2—skin cancer	0.000568	0.00627	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—PTGER4—skin cancer	0.000567	0.00626	CbGpPWpGaD
Icosapent—Anaphylactic shock—Docetaxel—skin cancer	0.00055	0.0061	CcSEcCtD
Icosapent—Pruritus—Fluorouracil—skin cancer	0.00054	0.00598	CcSEcCtD
Icosapent—ACSL3—Metabolism—PLIN2—skin cancer	0.000536	0.00592	CbGpPWpGaD
Icosapent—Vomiting—Temozolomide—skin cancer	0.000526	0.00584	CcSEcCtD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—skin cancer	0.000523	0.00577	CbGpPWpGaD
Icosapent—Rash—Temozolomide—skin cancer	0.000522	0.00579	CcSEcCtD
Icosapent—Dermatitis—Temozolomide—skin cancer	0.000521	0.00578	CcSEcCtD
Icosapent—PTGS1—head—skin cancer	0.00052	0.00293	CbGeAlD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000513	0.00566	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000501	0.00556	CcSEcCtD
Icosapent—PTGS2—head—skin cancer	0.000497	0.0028	CbGeAlD
Icosapent—FFAR1—GPCR downstream signaling—MC1R—skin cancer	0.000487	0.00538	CbGpPWpGaD
Icosapent—Vomiting—Fluorouracil—skin cancer	0.000485	0.00538	CcSEcCtD
Icosapent—Dyspepsia—Docetaxel—skin cancer	0.000485	0.00537	CcSEcCtD
Icosapent—Rash—Fluorouracil—skin cancer	0.000481	0.00533	CcSEcCtD
Icosapent—Dermatitis—Fluorouracil—skin cancer	0.00048	0.00533	CcSEcCtD
Icosapent—Gastrointestinal disorder—Docetaxel—skin cancer	0.000475	0.00527	CcSEcCtD
Icosapent—PTGS1—Eicosanoid Synthesis—PTGS2—skin cancer	0.000471	0.0052	CbGpPWpGaD
Icosapent—Constipation—Docetaxel—skin cancer	0.000471	0.00522	CcSEcCtD
Icosapent—FADS1—Metabolism—PLIN2—skin cancer	0.00045	0.00496	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—MC1R—skin cancer	0.000443	0.00488	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CSPG4—skin cancer	0.000442	0.00488	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—CSPG4—skin cancer	0.000432	0.00477	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—CDK4—skin cancer	0.000419	0.00462	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PLIN2—skin cancer	0.000407	0.00449	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PLIN2—skin cancer	0.000407	0.00449	CbGpPWpGaD
Icosapent—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—skin cancer	0.000394	0.00435	CbGpPWpGaD
Icosapent—PPARG—Transcription factor regulation in adipogenesis—IL6—skin cancer	0.000393	0.00434	CbGpPWpGaD
Icosapent—Pruritus—Docetaxel—skin cancer	0.000389	0.00432	CcSEcCtD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—skin cancer	0.000374	0.00413	CbGpPWpGaD
Icosapent—PPARG—Transcriptional regulation of white adipocyte differentiation—CDK4—skin cancer	0.000371	0.00409	CbGpPWpGaD
Icosapent—PTGS1—lymph node—skin cancer	0.000364	0.00205	CbGeAlD
Icosapent—FADS1—Metabolism—CSPG4—skin cancer	0.000362	0.004	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PTCH2—skin cancer	0.000362	0.00399	CbGpPWpGaD
Icosapent—Vomiting—Docetaxel—skin cancer	0.00035	0.00388	CcSEcCtD
Icosapent—PTGS2—lymph node—skin cancer	0.000348	0.00196	CbGeAlD
Icosapent—Rash—Docetaxel—skin cancer	0.000347	0.00385	CcSEcCtD
Icosapent—Dermatitis—Docetaxel—skin cancer	0.000347	0.00385	CcSEcCtD
Icosapent—ACSL4—Metabolism—CSPG4—skin cancer	0.000328	0.00362	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—CSPG4—skin cancer	0.000328	0.00362	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—PTGER4—skin cancer	0.00032	0.00354	CbGpPWpGaD
Icosapent—PPARG—Regulation of retinoblastoma protein—CDKN2A—skin cancer	0.00032	0.00353	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—SHH—skin cancer	0.000315	0.00348	CbGpPWpGaD
Icosapent—PTGS1—Overview of nanoparticle effects—IL6—skin cancer	0.00031	0.00342	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—PTCH1—skin cancer	0.000299	0.0033	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—SMO—skin cancer	0.000299	0.0033	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—SCN10A—skin cancer	0.000297	0.00328	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000295	0.00326	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—ENO2—skin cancer	0.000294	0.00324	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—skin cancer	0.000291	0.00321	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—PTGER4—skin cancer	0.000291	0.00321	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.00028	0.00309	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—GLI2—skin cancer	0.000274	0.00302	CbGpPWpGaD
Icosapent—PTGS1—Arachidonic acid metabolism—PTGS2—skin cancer	0.000262	0.00289	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MC1R—skin cancer	0.000261	0.00288	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—GLI1—skin cancer	0.000258	0.00284	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000254	0.0028	CbGpPWpGaD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL6—skin cancer	0.000248	0.00273	CbGpPWpGaD
Icosapent—FADS1—Metabolism—ENO2—skin cancer	0.000246	0.00272	CbGpPWpGaD
Icosapent—PTGS2—Overview of nanoparticle effects—IL6—skin cancer	0.000246	0.00271	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SUFU—skin cancer	0.000244	0.00269	CbGpPWpGaD
Icosapent—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—skin cancer	0.000231	0.00254	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.00023	0.00254	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PLIN2—skin cancer	0.000229	0.00252	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—ENO2—skin cancer	0.000223	0.00246	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—ENO2—skin cancer	0.000223	0.00246	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000216	0.00238	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000207	0.00228	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000204	0.00226	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000196	0.00217	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000194	0.00214	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000193	0.00213	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SHH—skin cancer	0.000186	0.00205	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—RASA1—skin cancer	0.000185	0.00204	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CSPG4—skin cancer	0.000184	0.00203	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SMO—skin cancer	0.000177	0.00195	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PTCH1—skin cancer	0.000177	0.00195	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	0.000174	0.00192	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—IL6—skin cancer	0.000174	0.00192	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000173	0.00191	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—CDK4—skin cancer	0.000172	0.0019	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PTGER4—skin cancer	0.000172	0.0019	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—RASA1—skin cancer	0.000171	0.00188	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—ERCC2—skin cancer	0.000171	0.00188	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—PTGS2—skin cancer	0.000167	0.00184	CbGpPWpGaD
Icosapent—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	0.000165	0.00182	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000156	0.00172	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—FOXO4—skin cancer	0.000152	0.00168	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000149	0.00164	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—CDKN2A—skin cancer	0.000147	0.00162	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CDK4—skin cancer	0.000146	0.00162	CbGpPWpGaD
Icosapent—FADS1—Metabolism—ERCC2—skin cancer	0.000143	0.00158	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—NRAS—skin cancer	0.000137	0.00152	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—ERCC2—skin cancer	0.000129	0.00143	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—ERCC2—skin cancer	0.000129	0.00143	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000127	0.0014	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ENO2—skin cancer	0.000125	0.00138	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PLIN2—skin cancer	0.000125	0.00138	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—KRAS—skin cancer	0.000118	0.0013	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—NRAS—skin cancer	0.000107	0.00118	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—TP53—skin cancer	0.000105	0.00116	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—PTGS2—skin cancer	0.000102	0.00113	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TERT—skin cancer	0.000101	0.00112	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CSPG4—skin cancer	0.000101	0.00111	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—HRAS—skin cancer	0.000101	0.00111	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	9.96e-05	0.0011	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.79e-05	0.00108	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—IL6—skin cancer	9.49e-05	0.00105	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—ERCC2—skin cancer	9.35e-05	0.00103	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	9.2e-05	0.00101	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	9.08e-05	0.001	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PLIN2—skin cancer	8.74e-05	0.000964	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PTGS2—skin cancer	8.58e-05	0.000946	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—NRAS—skin cancer	8.55e-05	0.000943	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—CDK4—skin cancer	8.38e-05	0.000924	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—BRAF—skin cancer	8.03e-05	0.000886	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	7.82e-05	0.000863	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PTGS2—skin cancer	7.76e-05	0.000856	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PTGS2—skin cancer	7.76e-05	0.000856	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—KRAS—skin cancer	7.35e-05	0.000811	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—TP53—skin cancer	7.32e-05	0.000807	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ERCC2—skin cancer	7.27e-05	0.000802	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	7.21e-05	0.000795	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CSPG4—skin cancer	7.05e-05	0.000777	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PLIN2—skin cancer	6.94e-05	0.000765	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ENO2—skin cancer	6.84e-05	0.000754	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—IL6—skin cancer	6.7e-05	0.000739	CbGpPWpGaD
Icosapent—PTGS2—Disease—CSPG4—skin cancer	6.68e-05	0.000737	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HRAS—skin cancer	6.25e-05	0.00069	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TP53—skin cancer	6.23e-05	0.000687	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL6—skin cancer	5.98e-05	0.00066	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL6—skin cancer	5.7e-05	0.000629	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CSPG4—skin cancer	5.59e-05	0.000617	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.35e-05	0.00059	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—ERCC2—skin cancer	5.11e-05	0.000563	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NRAS—skin cancer	5.05e-05	0.000557	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ENO2—skin cancer	4.79e-05	0.000528	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	4.77e-05	0.000526	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—NRAS—skin cancer	4.66e-05	0.000514	CbGpPWpGaD
Icosapent—PTGS2—Disease—ENO2—skin cancer	4.54e-05	0.000501	CbGpPWpGaD
Icosapent—PTGS2—Disease—SHH—skin cancer	4.54e-05	0.000501	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTGS2—skin cancer	4.36e-05	0.000481	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KRAS—skin cancer	4.34e-05	0.000479	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.24e-05	0.000468	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—KRAS—skin cancer	4.01e-05	0.000442	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ERCC2—skin cancer	3.97e-05	0.000438	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TP53—skin cancer	3.86e-05	0.000426	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ENO2—skin cancer	3.8e-05	0.000419	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.75e-05	0.000413	CbGpPWpGaD
Icosapent—PTGS2—Disease—FOXO4—skin cancer	3.7e-05	0.000408	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRAS—skin cancer	3.69e-05	0.000407	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL6—skin cancer	3.53e-05	0.00039	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—HRAS—skin cancer	3.41e-05	0.000376	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—IL6—skin cancer	3.26e-05	0.00036	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ERCC2—skin cancer	2.78e-05	0.000307	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERCC2—skin cancer	2.64e-05	0.000291	CbGpPWpGaD
Icosapent—PTGS2—Disease—TERT—skin cancer	2.47e-05	0.000273	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTGS2—skin cancer	2.38e-05	0.000263	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ERCC2—skin cancer	2.21e-05	0.000244	CbGpPWpGaD
Icosapent—PTGS2—Disease—BRAF—skin cancer	1.96e-05	0.000216	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTGS2—skin cancer	1.67e-05	0.000184	CbGpPWpGaD
Icosapent—PTGS2—Disease—NRAS—skin cancer	1.23e-05	0.000136	CbGpPWpGaD
Icosapent—PTGS2—Disease—KRAS—skin cancer	1.06e-05	0.000117	CbGpPWpGaD
Icosapent—PTGS2—Disease—HRAS—skin cancer	9e-06	9.93e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6—skin cancer	8.61e-06	9.5e-05	CbGpPWpGaD
